United kingdom prospective diabetes study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy

United kingdom prospective diabetes study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy

ग्रंथसूची विवरण
मुख्य लेखकों:	Wright, A, Cull, C, Holman, R, Turner, R, Murchison, L, Oakley, N, Kohner, E, Hayes, R, Scarpello, J, Hadden, D, Spathis, A, Yudkin, J, Greenwood, R, Borthwick, L, Day, J, Newton, R, Fox, C, Paisey, R, Roland, J, Humphriss, D, Peacock, I, Boulton, A, Dornan, T, Burden, F
स्वरूप:	Journal article
प्रकाशित:	1998

समान संसाधन

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
द्वारा: Wright, A, और अन्य
प्रकाशित: (2002)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
द्वारा: Cull, C, और अन्य
प्रकाशित: (1995)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
द्वारा: Wright, A, और अन्य
प्रकाशित: (1998)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
द्वारा: Turner, R, और अन्य
प्रकाशित: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
द्वारा: Turner, R, और अन्य
प्रकाशित: (1999)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
द्वारा: Wright, A, और अन्य
प्रकाशित: (2006)

DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
द्वारा: Eeley, E, और अन्य
प्रकाशित: (1992)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
द्वारा: Turner, R, और अन्य
प्रकाशित: (1995)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
द्वारा: Cull, C, और अन्य
प्रकाशित: (2000)

Low branched chain amino acids and tyrosine in Thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies
द्वारा: Sriboonvorakul, N, और अन्य
प्रकाशित: (2021)

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
द्वारा: Karunakaran, S, और अन्य
प्रकाशित: (1997)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
द्वारा: Turner, R, और अन्य
प्रकाशित: (1998)

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.
द्वारा: Cook, M, और अन्य
प्रकाशित: (2005)

HYPERTENSION IN DIABETES STUDY (HDS) .1. PREVALENCE OF HYPERTENSION IN NEWLY PRESENTING TYPE-2 DIABETIC-PATIENTS AND THE ASSOCIATION WITH RISK-FACTORS FOR CARDIOVASCULAR AND DIABETIC COMPLICATIONS
द्वारा: Turner, R, और अन्य
प्रकाशित: (1993)

Efficacy of sulfonylurea treatment for glycaemic control in diabetes: a systematic review and meta-analysis
द्वारा: Farmer, A, और अन्य
प्रकाशित: (2012)

Estimating the effect of sulfonylurea on HbA in diabetes: A systematic review and meta-analysis
द्वारा: Hirst, J, और अन्य
प्रकाशित: (2013)

COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
द्वारा: Holman, R, और अन्य
प्रकाशित: (1977)

Insulin therapy in type II diabetes.
द्वारा: Holman, R, और अन्य
प्रकाशित: (1995)

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
द्वारा: Hanefeld, M, और अन्य
प्रकाशित: (2004)

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
द्वारा: Rachman, J, और अन्य
प्रकाशित: (1997)

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.
द्वारा: Turner, R, और अन्य
प्रकाशित: (1993)

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
द्वारा: Sagen, J, और अन्य
प्रकाशित: (2004)

Ethnic differences in diabetic nephropathy - The UKPDS
द्वारा: Stevens, R, और अन्य
प्रकाशित: (1999)

UK prospective study of therapies of maturity-onset diabetes.
द्वारा: Turner, R, और अन्य
प्रकाशित: (1984)

RANDOMIZED CONTROLLED TRIAL OF SULFONYLUREA THERAPY IN 227 SUBJECTS WITH PERSISTENT FASTING HYPERGLYCEMIA
द्वारा: Karunakaran, S, और अन्य
प्रकाशित: (1995)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
द्वारा: Preiss, D, और अन्य
प्रकाशित: (2016)

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
द्वारा: Hirst, J, और अन्य
प्रकाशित: (2013)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
द्वारा: Eeley, E, और अन्य
प्रकाशित: (1996)

Poor pregnancy outcome for women with Type 2 diabetes.
द्वारा: Hadden, DR, और अन्य
प्रकाशित: (2003)

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
द्वारा: Holman, R
प्रकाशित: (2006)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
द्वारा: Cull, C, और अन्य
प्रकाशित: (2001)

Optimized diabetes therapy knowledge-based systems: Safety critical issues
द्वारा: Nealon, J, और अन्य
प्रकाशित: (1994)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
द्वारा: Eeley, E, और अन्य
प्रकाशित: (1996)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
द्वारा: Adler, A, और अन्य
प्रकाशित: (2000)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
द्वारा: Rachman, J, और अन्य
प्रकाशित: (1998)

Addition of insulin to oral therapy in type 2 diabetes - Reply
द्वारा: Holman, R, और अन्य
प्रकाशित: (2008)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
द्वारा: Cull, C, और अन्य
प्रकाशित: (1999)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
द्वारा: Stratton, I, और अन्य
प्रकाशित: (1993)

The foot in diabetes /
द्वारा: Boulton, A. J. M. (Andrew James Michael), और अन्य
प्रकाशित: (2006)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
द्वारा: Kohner, E, और अन्य
प्रकाशित: (1993)